GFACX | NASDX | GFACX / NASDX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 25 years | - |
Gain YTD | 3.356 | 2.028 | 166% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 303B | 1.92B | 15,781% |
Annual Yield % from dividends | 0.00 | 0.39 | - |
Returns for 1 year | 19.88 | 16.92 | 118% |
Returns for 3 years | 7.80 | 19.13 | 41% |
Returns for 5 years | 36.07 | 93.19 | 39% |
Returns for 10 years | 65.62 | 286.15 | 23% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FEAAX | 46.53 | 0.61 | +1.33% |
Fidelity Advisor Emerging Asia A | |||
FGITX | 42.48 | 0.35 | +0.83% |
Fidelity Advisor Growth & Income M | |||
JIECX | 17.57 | 0.08 | +0.46% |
JPMorgan International Equity C | |||
MSCUX | 11.72 | 0.04 | +0.34% |
Morgan Stanley American Resilience A | |||
HLHIX | 29.38 | N/A | N/A |
Virtus KAR Health Sciences Inst |